Pages Menu
TwitterRssFacebook

Posted by on Apr 15, 2016 in AdvisorShares, Impact

What a Ride! AdvisorShares at Cycle for Survival

What a Ride! AdvisorShares at Cycle for Survival

  Equinox gym in Bethesda blazed orange (a color close to our hearts) on March 6th for the 10th Annual Cycle for Survival. The day was filled with upbeat music, inspirational speeches, power sprints, and LOTS of camaraderie. There was extra excitement when we learned that CFS had crossed $100 million in all-time fundraising that week! AdvisorShares’ team, AlphaSquad, took to the bikes at 1:00 with lead-off rider James Fifield who commented “Hearing the stories from the survivors reminded me why I signed up. Their strength, their determination and their passion, not only the organization and event, but giving back to those that are currently fighting cancer. It was a powerful and moving experience.” Next on the bike was team captain, Nancy Fitzgerald, who was extremely impressed with the volunteers. “I did this event twice this weekend with two different teams, one in DC on Friday night, and one here in Bethesda Sunday afternoon. I can’t get over that most of these amazingly energetic volunteers are the same ones....

Read More

Posted by on Feb 12, 2016 in AdvisorShares, Impact

AdvisorShares Turns Our Attention to Rare Cancer Research – CYCLE FOR SURVIVAL

AdvisorShares Turns Our Attention to Rare Cancer Research – CYCLE FOR SURVIVAL

According to the National Institutes of Health (NIH), a “rare cancer” is one with a prevalence of fewer than 200,000 affected individuals in the United States. But when you put all of these rare cancer types together, they account for approximately half of all cancer diagnoses. Research on many rare cancers is drastically underfunded, often leaving patients with limited or no treatment options. Memorial Sloan Kettering Cancer Center—the world’s oldest and largest private cancer center—is committed to changing that reality. Cycle for Survival‘s indoor team cycling events raise funds that are critical for rare cancer research. 100% of every donation to Cycle for Survival is directly allocated to research at Memorial Sloan Kettering Cancer Center within six months of the events. Thanks to the tremendous efforts of participants, donors, and supporters, Cycle for Survival has raised over $80 million for rare cancer research, and funded 100+ clinical trials and research studies. On Sunday, March 6th from 1:00pm to 5:00pm AdvisorShares very own team, AlphaSquad, will Join the Battle! We are...

Read More

Posted by on Jan 21, 2016 in AdvisorShares, ETF Education

ETF Mechanics and Liquidity

ETF Mechanics and Liquidity

By Rob Parker, CFA, Director of Capital Markets   When a stock or a bond is traded, the traded price is the value of the security.  This is due to the fact that stocks and bonds are non-derivative securities.  Their value is driven solely by supply and demand at the moment of the trade.1  The supply of the security is fixed.2 There exists a whole array of derivatives in the marketplace, such as futures, options, and exchange-traded products (ETPs).  One such ETP of note is a closed-end fund (CEF).  In this structure, the issuer creates a static amount of shares that are traded on an exchange.  This unique structure can lead to differences between price and value (discount or premium).  Because CEFs are derivatives, their value is easily calculated by summing the values of the underlying holdings.  However, they are subject to their own demand paired with an inelastic supply. Moving further along the spectrum are exchange-traded funds (ETFs).  Like CEFs, the value of an ETF is easily quantified. ...

Read More

Posted by on Jul 27, 2015 in AdvisorShares, ETF Strategist, Market Insight

AdvisorShares Weekly Market Review – Week Ending 7/24/2015

AdvisorShares Weekly Market Review – Week Ending 7/24/2015

Markets Wilt In Summer Heat Macro Domestic equities had a down week despite some of the more sensational news headlines having become less sensational perhaps bringing earnings and inter-market dynamics back to the forefront as influencers of price. The news wasn’t horrible; sure a couple of earnings misses but there were some home runs as well yet markets sort of just eroded or maybe wilted is a better word. The Dow Jones Industrial Average fell 2.85% weighed down by everyone’s favorite tablet company, the S&P 500 dropped 2.20%, the NASDAQ gave up 2.31% and the Russell 2000 endured a 3.18% decline. Looking at foreign equities Europe was down and the eastern markets were mixed. The FTSE 100 fell 2.88%, the CAC 40 was down 1.28% and Germany gave up 2.79%. On the downside, Australia and the Hang Seng were down 1.83% and 1.13% respectively while the Nikkei was up 3.87% and Shanghai Composite had another positive week gaining 2.87%, which was soon forgotten as that index fell more than...

Read More

Posted by on Dec 29, 2014 in AdvisorShares, ETF Strategist, Market Insight

AdvisorShares Weekly Market Review – Week Ending 12/26/2014

AdvisorShares Weekly Market Review – Week Ending 12/26/2014

Highlights of the Prior Week – Christmas Week: Not Much Happened Macro Last week’s Market Update marveled at how many different things occurred (Cuba is on its way to being free!) even using the word epic in our description of events. Fast forward to Christmas week in which very little happened. There were a couple of milestones reached though as the Dow Jones Industrial Average closed above 18,000 and the assets held in ETFs crossed the $2 trillion mark. US Equities were higher last week on an expectedly light holiday volume. The Dow Jones Industrial Average gained 1.39%, the S&P 500 was up 0.86%, the NASDAQ added 0.88% as it inched closer to 5000 and the Russell 2000 was up 1.60%. Germany was only open for two days last week and gained 1.38%. France was open for three days and was also up 1.38% while the FTSE 100 was up 0.90% for the same three day period. Hong Kong and Australia also had three day weeks and rose 1.05%...

Read More